openPR Logo
Press release

IVD Market in Europe Expected to Cross $26,623 million by 2023

03-25-2020 03:40 PM CET | Health & Medicine

Press release from: Allied Market Research

IVD Market

IVD Market

Europe IVD Market is projected to reach at $26,623 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023.

In vitro diagnostic tests are performed using biological samples to detect the health ailments and other diseases. Rise in technological developments in IVD techniques, increase in incidence and prevalence of chronic and infectious diseases and increase in government healthcare expenditure in the European region drive the market growth. However, stringent government regulations related to the safety and efficacy of the IVD and unfavorable reimbursement policies are expected to restrain the market growth during the forecast period.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4352

Based on product type, the reagents segment held the highest market share of third-fifths in 2016, due to introduction of efficacious reagents in the market that are utilized in IVD technology for the detection of several disease.

Based on technique, the immunodiagnostics segment contributed the highest market share (one-third) in 2016, owing to the increase in prevalence of chronic diseases such as cancer that is analyzed by tissue or other diagnostic techniques and increase in demand for non-invasive techniques.

Based on application, the infectious diseases segment contributed the highest market share (two-sevenths) in 2016, owing to the increase in prevalence of infectious diseases such as tuberculosis, malaria, and pertussis that fuel the IVD market.

Based on end users, the standalone laboratory segment captured the highest market share (third-sevenths) in 2016, mainly due to availability of complex tests that are difficult to perform and increase in healthcare expenditure thus improving healthcare facilities.

Germany accounted for the highest shares in 2016, and is expected to dominate the market throughout the forecast period and is attributed to increase in incidence of chronic diseases such as tuberculosis, diabetes, and cancer. In addition, rise in demand for non-invasive technology, advancement in technology, and well-established healthcare systems is anticipated to provide new growth opportunities for the key players in the market. However, France is estimated to register the highest growth rate during the forecast period, owing to rise in government healthcare expenditure and growth in demand for healthcare devices from large pool of patient population, and improvement in healthcare infrastructure.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4352

Key Findings of the Europe IVD Market:
o The reagents segment dominated the market in 2016, and is projected to grow at the 3.7% CAGR.
o The immunodiagnostics segment accounted for the highest share in 2016.
o The pathology segment was the major shareholder in the Europe IVD market in 2016.
o The standalone laboratory segment accounted for the highest share in 2016.
o UK was the major shareholder of Europe IVD market in 2016.
o Germany is expected to grow at the highest CAGR in the Europe IVD market.

The major players profiled in the Europe IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IVD Market in Europe Expected to Cross $26,623 million by 2023 here

News-ID: 1984313 • Views: 146

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for IVD

Bioinformatics in IVD Testing Market : Global Forecast Over 2024
Global Bioinformatics in IVD Testing Market: Overview Bioinformatics, a multidisciplinary research field, is a combination of biology, computer science, mathematics, and statistics for managing the proliferating biological information. The software and applications in bioinformatics is leveraged to accumulate, examine, store, and integrate biological and genetic information. Those can be used later on for gene based drug development. The computer diagnostics creates opportunities for pathologists and clinicians for culturing viruses and
Global IVD Products Market Research Report
This report studies the global IVD Products market status and forecast, categorizes the global IVD Products market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Abbott Laboratories Danaher Corporation Johnson and Johnson Roche Diagnostics Siemens Healthcare BD Biomerieux Bio-Rad Laboratories Ortho Clinical
American IVD Market - Latest Trends, Forecast, Opportunity and Growth Analysis
Stratview Research announces the launch of a new research report on the American IVD Market - by Products & Services (Equipment, Reagents, Services, other), by Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, others), by Therapeutic Area (Infectious Diseases, Tropical Diseases, Lifestyle Disease, Neurology, Oncology, others), by End User (Hospital, Hospital Bed Side, Home Users, Research Labs), By Domestic Versus Global Competition, and by Key Export/Import Destinations. The report covers comprehensive view
Bioinformatics in IVD Testing Market Objectives and Detailed Study 2019
WiseGuyReports.Com Publish a New Market Research Report On –“ Bioinformatics in IVD Testing Market Objectives and Detailed Study 2019”. Description:- Bioinformatics is a multidisciplinary research field that combines computer science, biology, statistics and mathematics for the management of biological information. Scope of the Report: This report studies the Bioinformatics in IVD Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this
UK IVD Market Expected to Reach $3,127 million by 2023
In-vitro diagnostics (IVD) is the technique in which medical devices and reagents are utilized to analyze biological samples such as blood, urine, stool, tissues, and other body fluids, derived from the human body to detect diseases and infections. In addition, the tests are performed in stand-alone laboratory, and hospital-based laboratory. Some of the significant technologies incorporated in in vitro diagnostics include polymerase chain reaction, microarray techniques, sequencing technology and mass
In Vitro Diagnostic/IVD Market Worth $87.21 Billion By 2024
A report into the projected growth of the current IVD market by Meticulous Research® has produced lucrative forecasts for the industry. By 2024, the global IVD market is expected to reach $87.21 billion, growing at a CAGR of 5.7% from 2018. Browse 237 market data tables and 42 figures spread through 301 pages and in-depth TOC on “IVD Market by Product (Reagent, Instruments, Software, Service), Technique [Immunoassay, Clinical Chemistry (Lipids, Renal,